IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 87 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2022. The put-call ratio across all filers is 5.07 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $715,182 | -16.0% | 13,780 | -3.0% | 0.05% | -20.0% |
Q2 2023 | $851,432 | +8.1% | 14,200 | -10.8% | 0.06% | -1.6% |
Q1 2023 | $787,332 | -39.3% | 15,925 | -29.9% | 0.06% | -51.6% |
Q4 2022 | $1,297,258 | +21.7% | 22,731 | 0.0% | 0.13% | +13.5% |
Q3 2022 | $1,066,000 | – | 22,731 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 576,923 | $17,200,000 | 9.25% |
Velan Capital Investment Management LP | 293,385 | $8,772,000 | 8.14% |
Paradigm Biocapital Advisors LP | 499,190 | $14,926,000 | 3.95% |
TANG CAPITAL MANAGEMENT LLC | 385,600 | $11,529,000 | 2.31% |
Rock Springs Capital Management LP | 2,552,034 | $76,306,000 | 1.92% |
Samsara BioCapital, LLC | 160,963 | $4,813,000 | 1.21% |
RTW INVESTMENTS, LP | 1,859,471 | $55,598,000 | 1.15% |
Pier Capital, LLC | 236,616 | $7,075,000 | 0.90% |
Avidity Partners Management LP | 1,363,800 | $40,778,000 | 0.85% |
Rhenman & Partners Asset Management AB | 170,472 | $5,097,000 | 0.50% |